sorafenib has been researched along with glucuronic acid in 2 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (glucuronic acid) | Trials (glucuronic acid) | Recent Studies (post-2010) (glucuronic acid) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 8,119 | 170 | 4,136 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baker, SD; Gibson, AA; Hu, S; Li, L; Orwick, SJ; Roberts, JL; Sparreboom, A; Zimmerman, EI | 1 |
| Gu, J; Guo, B; He, G; Qi, K; Shao, M; Wang, L; Xu, X; Yang, X | 1 |
2 other study(ies) available for sorafenib and glucuronic acid
| Article | Year |
|---|---|
Contribution of OATP1B1 and OATP1B3 to the disposition of sorafenib and sorafenib-glucuronide.
Topics: Animals; Antineoplastic Agents; Glucuronic Acid; HEK293 Cells; Humans; Liver-Specific Organic Anion Transporter 1; Mice; Mice, Transgenic; Neoplasms; Niacinamide; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Phenylurea Compounds; Solute Carrier Organic Anion Transporter Family Member 1B3; Sorafenib | 2013 |
UDP-glucose 6-dehydrogenase lessens sorafenib sensitivity via modulating unfolded protein response.
Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Glucuronic Acid; Humans; Liver Neoplasms; Sorafenib; Unfolded Protein Response; Uridine Diphosphate Glucose Dehydrogenase; Xenograft Model Antitumor Assays | 2022 |